+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-08-05Number of Pages: 85

Array Instruments Market (Technologies DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays End Users Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Forensic Centers, Veterinary Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Microarray is a collection of microscopic spots of DNA, RNA, oligonucleotides, proteins, peptides, cells, tissues and other compounds which are attached to a solid substrate. Other microarray platforms include use of microscopic beads. With the help of array instruments, these microarrays are used to measure gene expression levels simultaneously in a single reaction and also genotype multiple regions of genome. The global array instruments market is driven by the large number of patients awaiting diagnosis of the exact type of cancer, metabolic diseases, and post natal diseases along with the research on the causes and treatment for such diseases. Disease diagnosis and detection has been the most critical and beneficial microarray application for the diagnosis and prognosis of different types of diseases, majorly cancer.

At present, a broad range of microarray technologies are available in the market for research purpose. DNA microarray is the most traditional and widely accepted technology in the microarray field. Thus, it accounts for the largest share, in the total market, owing to improved accuracy and precision and wide acceptance by the end users. The advent of DNA microarray has accelerated the process of gene expression, disease diagnosis, drug discovery and SNP analysis. Protein microarray which is the second largest and the fastest growing technology is very effective in identifying protein-protein interactions, substrates of protein kinases and activities of proteins. Due to high throughput, high resolution and sensitivity, protein microarray is extensively used in proteomics for protein expression profiling. Gene expression is the largest application market followed by the drug discovery and diagnosis market. High cost associated with the instruments and need for expertise leads to decreased adoption of microarray technology, particularly in developing countries. Moreover, increase in awareness for disease diagnosis and introduction of cheaper instruments and reagents will together aid in maintaining the growing of microarray technologies. 

Cellular microarray and tissue microarray technologies are currently in nascent stage and have their own limitations. The major factors that limit the use of tissue microarray are tissue heterogeneity and high cost. Expensive nature of array instruments limits the use in general practice in several countries. Hence, researchers are working on constructing cost effective tissue microarrays. Certain drawbacks with the use of cellular microarray are related to sensitivity. Moreover, there is further need for development of automated image analysis and data acquisition.

Geographically, North America dominates the global microarray instruments market. Large proportion of technological advancement first is introduced in the U.S. since majority of the prime market players are domiciled in North America. Europe accounts for second position in the total market. Rising incidences of cancers and autoimmune diseases drive the demand for diagnosis and treatment of such diseases in the region. Simplification of analysis process, increased market consolidation, and cost containment of instruments and reagents will result in rapid adoption of research in microarrays field in the emerging markets. Developing countries in Asia-Pacific, the Middle East, Latin America and Africa would contribute to the growth of the global array instruments market. Advancement in technology leading to better specificity and sensitivity coupled with low cost and robustness would increase the demand for research using microarrays, which would boost the market growth. 

The leading players in the market for microarray instruments are Affymetrix, Inc., Illumina, Inc., Agilent Technologies, Molecular Devices, ArrayIt Corporation, ThermoFischer Scientific and others which include Bio-Rad Laboratories, ArrayJet, and Sigma Aldrich. Greater benefits are expected to be achieved by various companies with huge investments in automation of systems with improved analysis in the near future. 

global-array-instruments-market

This report on the array instruments market studies the current as well as future prospects of the market globally. Microarray technology though a traditional bio technological tool, is gaining a rapidly evolving and emerging technology. Microarrays concept and methodology was first introduced in 1983 by Tse Wen Chang in a scientific publication. The microarray industry grew significantly after the 1995 Science Paper by the Ron Davis and Pat Brown labs at Stanford University. The technology of DNA microarrays has become the most sophisticated and the most widely used, with the establishment of companies such as Affymetrix, Inc., Agilent Technologies, Illumina, Inc., ArrayIt  Corporation and others, while the use of protein, peptide, cells, tissue and carbohydrate microarrays are expanding. The technology is used to detect, assess and analyze the interaction between different molecules such as DNA, RNA, proteins, siRNA, pharmaceuticals, carbohydrates, and antibodies. This report includes an elaborate executive summary, which covers a market snapshot that provides overall information of various segments that are contained in the report. It also provides an overall information and data analysis of the global array instruments market with respect to market segments based on technology, end users as well as geographic regions. 

The array instruments market is segmented based on major technologies into four categories: DNA microarrays, protein microarrays, cellular microarrays and tissue microarrays. The market for these microarray technologies has been extensively analyzed based on usefulness, effectiveness, sales revenue of the instruments based on the technologies and geographic presence. The market size and forecast in terms of USD million for each technology type and end user segment has been provided for the period 2012 to 2020. The report on the array instruments market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2012 and 2013 as the base year.

The array instruments market is also segmented based on major end user areas of the major microarray technologies into four major categories: research and development laboratories, clinical diagnostic labs, agriculture research centers and veterinary laboratories. The market for these end users of microarray technologies has been extensively analyzed based on the percentage adoption of these technologies in these sectors. The market size and forecast in terms of USD million for each end user has been provided for the period 2012 to 2020. The report on the array instrument market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2012 and 2013 as the base year.

Geographically, the array instruments market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The report also includes the market size and forecast for each microarray technology in respective regions. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global array instruments market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key players’ market share analysis in 2013 in the array instruments market. 

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report also profiles major players in the array instrument market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Affymetrix, Inc., Illumina, Inc., Agilent Technologies, Inc., Molecular Devices, LLC, Bio-Rad Laboratories, Thermo Fischer Scientific, ArrayIt Corporation, and Sigma Aldrich Corporation.

The global array instruments market is segmented as follows:

Array Instruments Market, by Technology
  • DNA Microarrays
  • Protein Microarrays
  • Cellular Microarrays
  • Tissue Microarrays
Array Instruments Market, by End-Users
  • Research and Development Laboratories
  • Clinical Diagnostic Labs
  • Agriculture Research Centers
  • Veterinary Laboratories
  • Forensic Centers
Array Instruments Market, by Geography
  • North America
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays
  • Europe
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays
  • Asia-Pacific
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays
  • Rest of the World (RoW)
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays


 
 
Back To Top